Does testosterone therapy cause prostate growth?

Summary

In this six‑minute presentation, Dr. Kenneth DeLay reviews the historical concern that exogenous testosterone might enlarge the prostate or accelerate benign prostatic hyperplasia (BPH). He outlines the early animal studies that suggested a relationship, then contrasts those findings with contemporary human data, including randomized controlled trials and meta‑analyses that show no significant increase in prostate volume or PSA levels with appropriately monitored TTh. The speaker emphasizes the distinction between physiological testosterone levels and supraphysiologic dosing used in some research settings, noting that most clinical protocols aim to restore normal ranges rather than exceed them. He also touches on the role of androgen receptors in prostate tissue, explaining that while testosterone can stimulate prostate cells, the effect is modulated by local conversion to dihydrotestosterone (DHT) and by feedback mechanisms that limit unchecked growth. Finally, Dr. DeLay advises clinicians to continue routine prostate monitoring (PSA, digital rectal exam) when initiating TTh, but reassures patients that the therapy itself is not a proven driver of prostate enlargement. The video does not delve into specific patient case studies, and it avoids making definitive treatment recommendations, instead encouraging viewers to consult their urologist or endocrinologist for personalized advice. Throughout, the tone is cautious yet supportive of testosterone replacement when indicated, underscoring that the decision should balance potential benefits (e.g., improved libido, mood, muscle mass) against individual risk factors such as existing prostate disease. The content reflects a consensus view among many urologists and endocrinologists as of the latest guidelines, but it acknowledges that research is ongoing. Overall, the presentation aims to dispel a common myth, provide a brief evidence‑based overview, and promote informed discussion between patients and their healthcare providers regarding testosterone therapy and prostate health.

Key Takeaways

• ✓Current clinical evidence does not show a causal link between medically supervised testosterone therapy and prostate growth.
• ✓Most studies use physiologic dosing; supraphysiologic doses may have different effects and are not typical in clinical practice.
• ✓Routine prostate monitoring (PSA, DRE) remains recommended when starting testosterone therapy.
• ✓Androgen receptor activity in the prostate is complex and regulated by multiple hormonal pathways, not solely by circulating testosterone.
• ✓Patients should discuss personal risk factors and benefits with a qualified healthcare professional before initiating therapy.

What to Be Careful About

• ⚠The video simplifies nuanced research and should not replace a thorough medical evaluation.
• ⚠Patients with a history of prostate cancer or significant BPH should seek specialized urologic counsel before starting testosterone.

Topics

Key terms in this video

Related reviews

• Many Men Chose The Wrong Prostate Cancer Treatment: Here’s WhyThe Prostate Clinic
• Shrink ENLARGED PROSTATE in 7 Easy Steps (2026 confirmation)KenDBerryMD
• The REAL Reason Your Prostate Is EnlargedKenDBerryMD